Moreover, they found higher enzymatic activity of SIRT2 in postmortem brain tissue from patients with different neurodegenerative diseases (Parkinson’s disease (PD), PD with dementia, dementia with Lewy bodies (DLB), and Alzheimer’s disease (AD)) compared to control samples [50]. The gene discussed is SIRT2; the disease is early-onset autosomal dominant Alzheimer disease.